Skip to main content
High RiskFDAfda-F-0835-2020UNDECLARED ALLERGEN

Stonewall Kitchen, Ghost Pepper Salsa, Net Weight 454g (16oz), Ingredients: Tomatoes, Jalapeno Peppers, Onion, Tomato Puree, Green Chile ...

Category
Units Affected
4,800
Recall Date
March 5, 2020
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0835-2020.

Product is mislabeled as salsa but it contains queso and does not declare two allergens, specifically milk and soy.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0835-2020.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Stonewall Kitchen, Llc or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-0835-2020.

Stonewall Kitchen, LLC

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Stonewall Kitchen, Llc Recall FAQ

Stonewall Kitchen, Llc is the subject of a produce safety report: Stonewall Kitchen, Ghost Pepper Salsa, Net Weight 454g (16oz), Ingredients: Tomatoes, Jalapeno Peppers, Onion, Tomato Puree, Green Chile .... The notice was published on March 5, 2020 by the U.S. Food and Drug Administration (FDA). Approximately 4,800 units are potentially affected.